Product: Ranitidine Tablets, USP 150 mg, a.) 24 count bottles (NDC 71713-203-02), b.)95 count bottles (NDC 71713-203-05)  (Thirty Madison) OTC.
Reason for recall: CGMP Deviations: Presence of NDMA impurity detected in product.
Recall initiated: 20191001
Status: Completed
Classification: Class II
Recall type: Voluntary: Firm initiated